PASADENA, Calif., December 23, 2024--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has dosed the first subjects in a Phase 1/2a clinical trial of ARO-INHBE, the company ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Chiefs will face a Texans defense that looked dominant vs the Chargers ...

Orlando Brown Jr. sent hilarious message to former Chiefs teammates ahead of Week 18 ...